Your browser doesn't support javascript.
loading
Molecular Signature of Monocytes Shaped by the Shigella sonnei 1790-Generalized Modules for Membrane Antigens Vaccine.
Tondi, Serena; Siena, Emilio; Essaghir, Ahmed; Bozzetti, Benoît; Bechtold, Viviane; Scaillet, Aline; Clemente, Bruna; Marrocco, Mariateresa; Sammicheli, Chiara; Tavarini, Simona; Micoli, Francesca; Oldrini, Davide; Pezzicoli, Alfredo; Di Fede, Martina; Brazzoli, Michela; Ulivieri, Cristina; Schiavetti, Francesca.
Afiliação
  • Tondi S; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Siena E; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
  • Essaghir A; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Bozzetti B; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Bechtold V; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
  • Scaillet A; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
  • Clemente B; Preclinical Research & Development, GSK, 1330 Rixensart, Belgium.
  • Marrocco M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Sammicheli C; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Tavarini S; Department of Life Sciences, University of Siena, 53100 Siena, Italy.
  • Micoli F; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Oldrini D; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Pezzicoli A; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
  • Di Fede M; GSK Vaccines Institute for Global Health S.R.L. (GVGH), 53100 Siena, Italy.
  • Brazzoli M; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Ulivieri C; Preclinical Research & Development, GSK, 53100 Siena, Italy.
  • Schiavetti F; Preclinical Research & Development, GSK, 53100 Siena, Italy.
Int J Mol Sci ; 25(2)2024 Jan 17.
Article em En | MEDLINE | ID: mdl-38256189
ABSTRACT
Shigellosis, an acute gastroenteritis infection caused by Shigella species, remains a public health burden in developing countries. Recently, many outbreaks due to Shigella sonnei multidrug-resistant strains have been reported in high-income countries, and the lack of an effective vaccine represents a major hurdle to counteract this bacterial pathogen. Vaccine candidates against Shigella sonnei are under clinical development, including a Generalized Modules for Membrane Antigens (GMMA)-based vaccine. The mechanisms by which GMMA-based vaccines interact and activate human immune cells remain elusive. Our previous study provided the first evidence that both adaptive and innate immune cells are targeted and functionally shaped by the GMMA-based vaccine. Here, flow cytometry and confocal microscopy analysis allowed us to identify monocytes as the main target population interacting with the S. sonnei 1790-GMMA vaccine on human peripheral blood. In addition, transcriptomic analysis of this cell population revealed a molecular signature induced by 1790-GMMA mostly correlated with the inflammatory response and cytokine-induced processes. This also impacts the expression of genes associated with macrophages' differentiation and T cell regulation, suggesting a dual function for this vaccine platform both as an antigen carrier and as a regulator of immune cell activation and differentiation.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos de Grupos Sanguíneos / Vacinas / Gastroenterite / Metilmetacrilatos Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Antígenos de Grupos Sanguíneos / Vacinas / Gastroenterite / Metilmetacrilatos Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália